Internal Medicine, Cardiovascular Disease · Coral Gables, FL
NPI
1437196854
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
2733 Ponce de Leon Blvd
Coral Gables, FL, 33134
Phone (305) 444-8007
Groups this clinician bills Medicare through
Medicare paid, 2024
$72K
1,677 services
Medicare patients, 2024
185
Average age 77
Drug cost, 2024
$1.3M
4,225 prescriptions
Company payments, 2024
$16.05
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Donato J Arguelles I was code 36415 (venipuncture blood collection), 614 times for 175 patients. In total Donato J Arguelles I billed 1,677 services in 28 codes, and Medicare paid $72K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 36415 Venipuncture Blood Collection | Office | 614 | 175 | $8.65 | $5,311 |
| 99213 Office E&M - Established | Office | 347 | 154 | $66.10 | $23K |
| 93000 Electrocardiogram | Office | 167 | 129 | $10.63 | $1,776 |
| A9500 Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 94 | 47 | $96.46 | $9,067 |
| 78452 Myocardial Perfusion Scan | Office | 94 | 47 | $163.20 | $15K |
| 90471 Vaccine Administration | Office | 75 | 14 | $16.88 | $1,266 |
| 93015 Electrocardiogram | Office | 57 | 54 | $40.36 | $2,301 |
| 96372 Injection Administration | Office | 36 | 13 | $11.11 | $400 |
| 99214 Office E&M - Established | Office | 28 | 28 | $85.67 | $2,399 |
| 99442 Telephone Services | Office | 24 | 20 | $75.39 | $1,809 |
| 99212 Office E&M - Established | Office | 22 | 17 | $43.03 | $947 |
| 93288 External Electrocardiographic Monitoring | Office | 22 | 11 | $40.65 | $894 |
| J2785 Injection, regadenoson, 0.1 mg | Office | 16 | 16 | $7.46 | $119 |
| 93306 Echocardiography (TTE/TEE) | Office | 14 | 14 | $158.07 | $2,213 |
By year: 2022 $96K for 3,849 services; 2023 $88K for 3,034 services; 2024 $72K for 1,677 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 614 | 175 | $8.65 | $5,311 |
Medicare prescription drug claims, 2024
In 2024, the drug Donato J Arguelles I prescribed most often to Medicare patients was Repatha Sureclick (Evolocumab), with 603 prescriptions and refills. In total Donato J Arguelles I wrote 4,225 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Repatha Sureclick Evolocumab | 603 | 857 | 92 | $477K |
| Ezetimibe Generic | 196 | 552 | 80 | $5,187 |
| Alprazolam Generic | 152 | 152 | 38 | $1,234 |
| Losartan Potassium Generic | 120 | 315 | 31 | $1,926 |
| Mounjaro Tirzepatide | 95 | 107 | 12 | $114K |
| Atenolol Generic | 94 | 223 | 22 | $1,206 |
| Atorvastatin Calcium Generic | 89 | 231 | 25 | $966 |
| Prednisone Generic | 82 | 88 | 44 | $374 |
| Crestor Rosuvastatin Calcium | 82 | 112 | 15 | $30K |
| Azithromycin Generic | 80 | 80 | 57 | $595 |
| Ozempic Semaglutide | 78 | 103 | 15 | $97K |
| Jardiance Empagliflozin | 78 | 136 | 16 | $81K |
| Amlodipine Besylate Generic | 72 | 160 | 17 | $872 |
| Xarelto Rivaroxaban | 61 | 89 | Under 11 | $48K |
| Rosuvastatin Calcium Generic | 60 | 148 | 24 | $1,425 |
Brand drugs: - claims; generic drugs: 2,632 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Donato J Arguelles I $16.05 ($16.05 in general payments such as food, travel and fees) from 1 company. The largest payer was Novo Nordisk Inc with $16.05.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 1 | $16.05 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.